# Invesco DB US Dollar Index Bearish Fund: financial statements, quarterly

UDN · NYSE · CIK 1383149 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/udn.md) · [Financials](/companies/udn/financials.md) · [Filings](/companies/udn/filings.md) · [Insiders](/companies/udn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/udn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $k | [819](/filings/0000950170-24-122600.md) | [743 d](/filings/0001193125-26-083562.md) | [740](/filings/0000950170-25-067184.md) | [642](/filings/0000950170-25-105207.md) | [622](/filings/0001193125-25-270306.md) | [614 d](/filings/0001193125-26-083562.md) | [472](/filings/0001193125-26-209727.md) | [1,121](/filings/0001193125-26-338698.md) | [1,325](/filings/0001193125-25-270306.md) | [1,203 d](/filings/0001193125-26-083562.md) | [1,018](/filings/0001193125-26-209727.md) | [917](/filings/0001193125-26-338698.md) |
| Interest expense | $k | [1.9](/filings/0000950170-24-122600.md) | [1.6 d](/filings/0000950170-24-019053.md) | [1.6](/filings/0000950170-24-054957.md) | [1.5](/filings/0000950170-24-092092.md) | [1.2](/filings/0000950170-24-122600.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,779)](/filings/0000950170-24-122600.md) | [3,460 d](/filings/0001193125-26-083562.md) | [(1,540)](/filings/0000950170-25-067184.md) | [(260)](/filings/0000950170-25-105207.md) | [2,998](/filings/0001193125-25-270306.md) | [(4,648) d](/filings/0001193125-26-083562.md) | [2,324](/filings/0001193125-26-209727.md) | [7,934](/filings/0001193125-26-338698.md) | [(746)](/filings/0001193125-25-270306.md) | [(516) d](/filings/0001193125-26-083562.md) | [(2,332)](/filings/0001193125-26-209727.md) | [(433)](/filings/0001193125-26-338698.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [63.5](/filings/0000950170-23-060465.md) | [65.5](/filings/0000950170-25-027260.md) | [62.2](/filings/0000950170-24-054957.md) | [52.8](/filings/0000950170-24-092092.md) | [73.5](/filings/0000950170-24-122600.md) | [51.3](/filings/0001193125-26-083562.md) | [69.3](/filings/0000950170-25-067184.md) | [148](/filings/0000950170-25-105207.md) | [156](/filings/0001193125-25-270306.md) | [139](/filings/0001193125-26-338698.md) | [143](/filings/0001193125-26-209727.md) | [113](/filings/0001193125-26-338698.md) |
| Total liabilities | $m | [0.0](/filings/0000950170-23-060465.md) | [0.1](/filings/0000950170-25-027260.md) | [0.2](/filings/0000950170-24-054957.md) | [0.0](/filings/0000950170-24-092092.md) | [10.1](/filings/0000950170-24-122600.md) | [0.3](/filings/0001193125-26-083562.md) | [0.0](/filings/0000950170-25-067184.md) | [0.1](/filings/0000950170-25-105207.md) | [0.1](/filings/0001193125-25-270306.md) | [0.1](/filings/0001193125-26-338698.md) | [0.1](/filings/0001193125-26-209727.md) | [5.4](/filings/0001193125-26-338698.md) |
| Shareholders' equity | $m | [63.4](/filings/0000950170-24-122600.md) | [65.4](/filings/0001193125-26-083562.md) | [62.1](/filings/0000950170-25-105207.md) | [52.8](/filings/0001193125-25-270306.md) | [63.4](/filings/0001193125-25-270306.md) | [51.0](/filings/0001193125-26-338698.md) | [69.2](/filings/0001193125-26-338698.md) | [148](/filings/0001193125-26-338698.md) | [156](/filings/0001193125-25-270306.md) | [139](/filings/0001193125-26-338698.md) | [143](/filings/0001193125-26-338698.md) | [107](/filings/0001193125-26-338698.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.2 d](/filings/0000950170-24-122600.md) | [1.5 d](/filings/0001193125-26-083562.md) | [1.8](/filings/0000950170-25-067184.md) | [9.0 d](/filings/0000950170-25-105207.md) | [(7.6) d](/filings/0001193125-25-270306.md) | [7.6 d](/filings/0001193125-26-083562.md) | [(15.8)](/filings/0001193125-26-209727.md) | [(71.2) d](/filings/0001193125-26-338698.md) | [(8.5) d](/filings/0001193125-25-270306.md) | [17.0 d](/filings/0001193125-26-083562.md) | [(6.8)](/filings/0001193125-26-209727.md) | [30.1 d](/filings/0001193125-26-338698.md) |
| Share repurchases | $m | [15.8 d](/filings/0000950170-24-122600.md) | [1.9 d](/filings/0001193125-26-083562.md) | [2.7](/filings/0000950170-25-067184.md) | [10.8 d](/filings/0000950170-25-105207.md) | [2.7 d](/filings/0001193125-25-270306.md) | [14.3 d](/filings/0001193125-26-083562.md) | [5.0](/filings/0001193125-26-209727.md) | [0.9 d](/filings/0001193125-26-338698.md) | [6.5 d](/filings/0001193125-25-270306.md) | [16.7 d](/filings/0001193125-26-083562.md) | [17.2](/filings/0001193125-26-209727.md) | [40.2 d](/filings/0001193125-26-338698.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 6,000,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338698.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.